Raymond James & Associates’s Trillium Therapeutics Inc. TRIL Stock Holding History

Raymond James & Associates’s Portfolio TRIL Stock Details TRIL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$738K	Buy
2021 Q2	$348K	Buy
2021 Q1	$370K	Buy
2020 Q4	$200K	Buy